AI assistant
STERIS plc — Director's Dealing 2019
Jun 21, 2019
30229_dirs_2019-06-21_280681d2-b263-4fd7-8e0e-dab32bb4d595.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2019-06-20
Reporting Person: TOKICH MICHAEL J (Sr. Vice Pres., CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-20 | Ordinary Shares | M | 2014 | $45.34 | Acquired | 52579 | Direct |
| 2019-06-20 | Ordinary Sahres | S | 2014 | $146.12 | Disposed | 50565 | Direct |
| 2019-06-21 | Ordinary Shares | M | 19986 | $45.34 | Acquired | 70551 | Direct |
| 2019-06-21 | Ordinary Shares | S | 13696 | $143.17 | Disposed | 56855 | Direct |
| 2019-06-21 | Ordinary Shares | S | 6290 | $144.07 | Disposed | 50565 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-20 | Employee Stock Option (right to buy) | $45.34 | M | 2014 | Disposed | 2023-05-31 | Ordinary Shares (22000) | Direct |
| 2019-06-21 | Employee Stock Option (right to buy) | $45.34 | M | 19986 | Disposed | 2023-05-31 | Ordinary Shares (19986) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 3405 | Indirect |
Footnotes
F1: This Exercise and sale of a total of 2,014 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019.
F2: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
F3: Price reflects a weighted average sale price for multiple transactions ranging from $146.00 to $146.62 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019.
F5: Price reflects a weighted average sale price for multiple transactions ranging from $142.75 to $143.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6: Price reflects a weighted average sale price for multiple transactions ranging from $143.77 to $144.52 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7: 21,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023.
F8: Units representing 3,405 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 20, 2019.